A significant driver of top-line growth: China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. (AMEX: CPHI) stock fell -1.56% on Monday to $0.11 against a previous-day closing price of $0.11. With 1.19 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.37 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.1130 whereas the lowest price it dropped to was $0.1023. The 52-week range on CPHI shows that it touched its highest point at $0.53 and its lowest point at $0.08 during that stretch. Beta for the stock currently stands at 0.46.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPHI was down-trending over the past week, with a drop of -6.05%, but this was down by -9.16% over a month. Three-month performance dropped to -26.34% while six-month performance fell -48.01%. The stock lost -73.23% in the past year, while it has gained 11.68% so far this year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 19.00%.

Float and Shares Shorts:

At present, 50.02 million CPHI shares are outstanding with a float of 23.36 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.1 million, which was 0.20% higher than short shares on Sep 14, 2022. In addition to Ms. Zhilin Li as the firm’s Pres, CEO, Chairman & Interim CFO, Ms. Huang Na C.F.A. serves as its BOD Sec. & IR Mang.

Institutional Ownership:

Through their ownership of 1.56% of CPHI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 44.99% of CPHI, in contrast to 0.85% held by mutual funds. Shares owned by individuals account for 0.28%. As the largest shareholder in CPHI with 0.71% of the stake, Renaissance Technologies LLC holds 364,459 shares worth 364,459. A second-largest stockholder of CPHI, Bridgeway Capital Management LLC, holds 145,000 shares, controlling over 0.28% of the firm’s shares. Millennium Management LLC is the third largest shareholder in CPHI, holding 30,577 shares or 0.06% stake. With a 0.28% stake in CPHI, the Bridgeway Ultra Small Company Mar is the largest stakeholder. A total of 145,000 shares are owned by the mutual fund manager.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CPHI since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CPHI analysts setting a high price target of $4.50 and a low target of $4.50, the average target price over the next 12 months is $4.50. Based on these targets, CPHI could surge 3990.91% to reach the target high and rise by 3990.91% to reach the target low. Reaching the average price target will result in a growth of 3990.91% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CPHI will report FY 2011 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of $0.42 being high and $0.42 being low. For CPHI, this leads to a yearly average estimate of $0.42. Based on analyst estimates, the high estimate for the next quarter is $0.11 and the low estimate is $0.11. The average estimate for the next quarter is thus $0.11.

Summary of Insider Activity:

Insiders traded CPHI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *